Monothematic Conference 2016

“THE FUTURE OF LIVER DISEASES: BEYOND HCV IS THERE A ROLE FOR THE HEPATOLOGIST?"

Giovedì 13 Ottobre 2016

First Session “Hepatotropic Viruses”

DAA’s: the end of the HCV- related diseases? - A. Craxì, Palermo

Management of HBV infection between Specialist and General Practitioners - P. Lampertico, Milano

Hepatitis delta: sometimes they come back? M. Rizzetto, Torino

Lecture

Probiota and the liver - A. Gasbarrini, Roma

Venerdì 14 Ottobre 2016

Second Session “Hepatic Neoplasms”

Cholangiocarcinoma “on the rise” - D. Alvaro, Roma

HCC in eradicated patients - F. Farinati, Padova

The challenge for new drugs - M.A. Iavarone, Milano

Third Session “Liver Fibrosis”

Cirrhosis is different from Fibrosis - G. D’Amico, Palermo

Antifibrotic therapy between hopes and reality - F. Marra, Firenze

Fourth Session “Non-alcoholic Fatty Liver Disease”

Non-invasive diagnosis and outcome predictors - E. Vanni, Torino

The role of genetic - L. Valenti, Milano

Pharmacological approach - L. Miele, Roma

Cardiovascular disease and NAFLD - S. Petta, Palermo

Lectures

The new challenges of alcoholic liver disease - G. Addolorato, Roma

Toward Precision Medicine in Primary Biliary Cholangitis - M. Carbone, Rozzano (MI)

Sabato 15 Ottobre 2016

Fifth Session “Liver Transplant”

What is left after the viruses - S. Ginanni Corradini, Roma

Alcoholic liver disease as first indication - G. Germani, Padova

The optimal running of waiting list: which criteria? P. Toniutto, Udine